The U.S. government will start distributing Regeneron Pharmaceuticals Inc.’s newly authorized Covid-19 antibody combination on Nov. 24, beginning with more than 30,000 treatment courses, a health...
Merck & Co is to buy US biotech OncoImmune for at least $425m, adding a potential new therapy The post Merck & Co adds COVID-19 drug...
Merck acquired Maryland-based OncoImmune and the Covid-19 therapeutic candidate CD24Fc for $425 million in upfront cash two months after the Phase III asset demonstrated efficacy during...
Merck & Co has entered into a definitive agreement to snap up all of the outstanding shares of drugmaker OncoImmune for an upfront payment of $425...
$1 million grant will advance personalized medicine using gene editing at ChristianaCare’s Gene Editing Institute Credit: ChristianaCare Gene Editing Institute Scientists at ChristianaCare’s Gene Editing Institute...
Precision BioSciences shares surged 10.7% on Nov. 20 as the biotechnology company along with Eli Lilly (LLY) announced a research collaboration and exclusive license agreement to...
AstraZeneca said that its coronavirus vaccine candidate, which it is developing together with Oxford University, has shown an average efficiency of 70% and met the primary...
German digital health company smartpatient is adding a new section of its MyTherapy app providing information on wet The post Novartis taps smartpatient for app to...
Shares of Avrobio plunged 17.6% on Friday after the clinical-stage gene therapy company kicked off a secondary offering of 5 million common shares. The offering is...
The U.S. Food and Drug Administration issued emergency use authorization for Regeneron Pharmaceuticals Inc.’s Covid-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump...
Welcome To The Interregnum Tyler Durden Sun, 11/22/2020 - 11:15 Authored by Chris Martenson via PeakProsperity.com, We’re between things. It’s an uncomfortable place. We are transitioning...
Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency Use Authorization (EUA) by the US Food and...
The US Food and Drug Administration (FDA) will review Pfizer Inc. and BioNTech’s request for emergency use authoriziation (EUA) of their COVID-19 vaccine candidate on Dec....
General Electric has signed a memorandum of understanding (MoU) with EVN Genco3, a Vietnamese company, to develop a liquefied natural gas (LNG) power plant in the...
Pfizer Expected to File FDA EUA Application for COVID-19 Vaccine Today
Lilly’s baricitinib granted US emergency use in COVID-19
Mesoblast Teams Up With Novartis to Develop COVID-19/ARDS Stem Cell Therapy; Shares Up 17%
Eli Lilly Arthritis Drug Gets Emergency Green-Light As COVID-19 Treatment
NICE says yes to Braftovi combination for colorectal cancer
FDA Grants EUA to Combination of Olumiant and Remdesivir in Hospitalized Covid-19 Patients
Antibody cocktails at low doses could be more effective at treating COVID-19
Texas Heart Institute to participate in global stem cell study to treat ARDS due to COVID
3 innovations booming during COVID and how to adopt them successfully
Pharma needs to adapt its communications or be left behind
In the lab, St. Jude scientists identify possible COVID-19 treatment
4DMT shoots for a $75M IPO, its second attempt to go public with its gene therapy vector programs
Pfizer prepares to file COVID-19 shot after reaching safety milestone
Sanofi Wins FDA Priority Review For Enzyme Therapy; Street Bullish
U.S. hospitals to restrict Lilly Covid-19 antibody treatment due to limited supply
Promising results from in vitro combination therapy against COVID-19